Indian Journal of ECMO

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 1 , ISSUE 2 ( April-June, 2023 ) > List of Articles

CASE REPORT

Managing Hypercapnia in a Coronavirus Disease 2019 Acute Respiratory Distress Syndrome with Extracorporeal Carbon Dioxide Removal Using Continuous Renal Replacement Therapy Machine: A Case Report

Vivek Gupta, Bishav Mohan, Suvir Grover, Gurkirat Kaur, Gurpreet Singh Wander

Keywords : Acute respiratory distress syndrome, Continuous renal replacement therapy, Extracorporeal carbon dioxide removal, Pediatric oxygenator

Citation Information : Gupta V, Mohan B, Grover S, Kaur G, Wander GS. Managing Hypercapnia in a Coronavirus Disease 2019 Acute Respiratory Distress Syndrome with Extracorporeal Carbon Dioxide Removal Using Continuous Renal Replacement Therapy Machine: A Case Report. Indian J ECMO 2023; 1 (2):76-78.

DOI: 10.5005/jaypee-journals-11011-0008

License: CC BY-NC 4.0

Published Online: 23-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Coronavirus disease-2019 (COVID-19) acute respiratory distress syndrome (ARDS) management remains challenging for intensivists, especially during limited resource availability. We report a COVID-19 ARDS case who had hypercapnia in spite of appropriate ventilatory management. This case was successfully managed with the use of extracorporeal carbon dioxide removal (ECCO2R) device with attaching pediatric oxygenator with continuous renal replacement therapy (CRRT).


HTML PDF Share
  1. Cardinal–Fernández P, Lorente JA, Ballén–Barragán A, et al. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Ann Am Thorac Soc 2017;14(6):844–850. DOI: 10.1513/AnnalsATS.201609-728PS.
  2. Burnham EL, Janssen WJ, Riches DWH, et al. The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance. EurRespir J 2014;43(1):276–285. DOI: 10.1183/09031936.00196412.
  3. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir Med 2020;8(8):807–815. DOI: 10.1016/S2213-2600(20)30225-3.
  4. Thille AW, Esteban A, Fernández–Segoviano P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: A prospective cohort study of clinical autopsies. Lancet Respir Med 2013;1:395–401. DOI: 10.1016/S2213-2600(13)70053-5.
  5. Fanelli V, Ranieri MV, Mancebo J, et al. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress syndrome. Crit Care 2016;20:36. DOI: 10.1186/s13054-016-1211-y.
  6. Parrilla F, Bergesio L, Aguirre–Bermeo H, et al. Ultra-low tidal volumes and extracorporeal carbon dioxide removal (Hemolung® RAS) In ARDS patients: A clinical feasibility study. Intensive Care Med Exp 2015;3(Suppl. 1):A7. DOI: 10.1186/2197-425X-3-S1-A7.
  7. Kalbhenn J, Neuffer N, Zieger B, et al. Is extracorporeal CO2 removal really “safe” and “less” invasive? Observation of blood injury and coagulation impairment during ECCO2R. ASAIO J Am Soc Artif Intern Organs 2017;63:666–671. DOI: 10.1097/MAT.0000000000000544.
  8. Moss CE, Galtrey EJ, Camporota L, et al. A retrospective observational case series of low flow veno-venous extracorporeal carbon dioxide removal use in patients with respiratory failure. ASAIO J 2016;62(4):458–462. DOI: 10.1097/MAT.0000000000000386.
  9. Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: The SUPERNOVA study. Intensive Care Med 2019;45(5):592–600. DOI: 10.1007/s00134-019-05567-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.